AlloHeme Clinical Validation: CareDx Unveils AI Surveillance Test for AML and MDS
CareDx has announced strong AlloHeme clinical validation results, introducing the first AI-powered next-generation sequencing (NGS) surveillance test designed to predict relapse in patients with acute myeloid leukemia (AML) and...

